BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17659922)

  • 1. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
    Lee SW; Park SW; Park DW; Lee SW; Kim SH; Jang JS; Jeong YH; Kim YH; Lee CW; Hong MK; Yun SC; Kim JJ; Park SJ
    Am J Cardiol; 2007 Aug; 100(3):425-30. PubMed ID: 17659922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of diffuse in-stent restenosis with drug-eluting stents vs. intracoronary beta-radiation therapy: INDEED Study.
    Park SW; Lee SW; Koo BK; Park DW; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Mori K; Lansky AJ; Mintz GS; Lee MM; Park SJ
    Int J Cardiol; 2008 Dec; 131(1):70-7. PubMed ID: 18190986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
    Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
    Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
    Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
    JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis.
    Li JJ; Xu B; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Jul; 119(13):1059-64. PubMed ID: 16834923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.
    Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW
    Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial.
    Alli OO; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA; Holmes DR;
    Am Heart J; 2012 Mar; 163(3):438-45. PubMed ID: 22424015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary radiotherapy with a (188)rhenium liquid-filled PTCA balloon system in in-stent restenosis: acute and long-term angiographic results, as well as 1-year clinical follow-up.
    Reynen K; Köckeritz U; Kropp J; Wunderlich G; Knapp FF; Schmeisser A; Strasser RH
    Int J Cardiol; 2004 May; 95(1):29-34. PubMed ID: 15159034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence.
    Kuiper KK; Salem M; Rotevatn S; Mills J; Nordrehaug JE
    Cardiovasc Revasc Med; 2007; 8(1):9-14. PubMed ID: 17293263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent.
    Park CB; Hong MK; Kim YH; Park DW; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    Int J Cardiol; 2007 Sep; 120(3):387-90. PubMed ID: 17291608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiographic and clinical outcome for the treatment of in-stent restenosis with sirolimus-eluting stent compared to vascular brachytherapy.
    Pohl T; Kupatt C; Steinbeck G; Boekstegers P
    Z Kardiol; 2005 Jun; 94(6):405-10. PubMed ID: 15940441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions: clinical and ultrasound results from a randomised trial.
    Wiemer M; König A; Rieber J; Sohn HY; Leibig M; Theisen K; Klauss V; Langer C; Lindner O; Horstkotte D; Schiele TM
    EuroIntervention; 2011 Jan; 6(6):687-94. PubMed ID: 21205590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.
    Kandzari DE; Rao SV; Moses JW; Dzavik V; Strauss BH; Kutryk MJ; Simonton CA; Garg J; Lokhnygina Y; Mancini GB; Yeoh E; Buller CE;
    JACC Cardiovasc Interv; 2009 Feb; 2(2):97-106. PubMed ID: 19463409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.